Hologic Inc. (HOLX), a Medical diagnostic equipment maker on Monday reported a wider net loss in the second-quarter of $51.1 million or $0.19 per share, from $40.2 million or $0.15 per share in the same period last year. The latest quarter results were weighed down by a spike in total costs and expenses from the prior-year quarter.
On an adjusted basis the company posted a profit of $93.8 million or $0.35 per share. On average, 20 analysts polled by Thomson Reuters expected earnings of $0.34 per share for the quarter. Analysts' estimates typically exclude special items.
Costs of expenses during the quarter rose to $607.1 million from $467.0 million in the same year-ago period.
Meanwhile, quarterly revenues climbed to $612.66 million from $471.16 million in the comparable quarter a year ago, while fourteen analysts expected to see revenues of $639.44 million for the quarter.
Looking forward to the third quarter, the company expects adjusted earnings in a range of between $0.36 per share and $0.37 per share and to record revenues between $625 million and $630 million. Analysts currently estimate earnings of $0.41 per share on revenues of $655.24 million.
Further, the company cut its fiscal year 2013 revenue guidance to a range between $2.53 billion and $2.55 billion from its prior estimate of $2.61 billion to $2.64 billion, the company also scaled down its full year earnings guidance to a range between $1.54 per share and $1.56 per share, from its previous guidance between $1.58 and $1.60 per share.
Analysts currently estimate earnings of $1.58 per share on revenues of $2.62 billion for fiscal year 2013.
For comments and feedback: editorial@rttnews.com